Literature DB >> 31302818

Combined retro-peribulbar and subconjunctival anesthesia for evisceration surgery.

Bulent Yazici1, Ceren Poroy2, Ugur Yayla2.   

Abstract

PURPOSE: To evaluate the efficacy of retro-peribulbar and subconjunctival anesthesia associated with intravenous sedation in patients undergoing evisceration and orbital implant placement.
METHODS: The charts of 217 patients who underwent evisceration with trans-scleral implant placement were reviewed. Midazolam and fentanyl were used for intravenous sedation. For local anesthesia, a combination of lidocaine with epinephrine and bupivacaine was injected into the retrobulbar, upper peribulbar, and subconjunctival areas. The intraoperative pain and need for supplemental anesthetic injection were recorded prospectively.
RESULTS: The surgery was performed with local anesthesia in 116 patients (53%) and with general anesthesia in 101 patients (47%). Patients were significantly older in the local anesthesia group than in the general anesthesia group (mean age, 59.9 years vs 45.2 years; P < .05). Supplemental retrobulbar anesthesia was required in 5 patients (4.3%). Transition to general anesthesia was required in 1 patient (0.9%) due to severe anxiety. Orbital hemorrhage developed after retrobulbar injection in 1 patient (0.9%), but did not preclude performing evisceration.
CONCLUSIONS: Combined retro-peribulbar and subconjunctival anesthesia with intravenous sedation can provide safe and effective intraoperative analgesia for evisceration surgery with trans-scleral implant placement.

Entities:  

Keywords:  Complications; Evisceration; Local anesthesia; Orbital implant

Mesh:

Substances:

Year:  2019        PMID: 31302818     DOI: 10.1007/s10792-019-01144-2

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  22 in total

Review 1.  Preemptive analgesia.

Authors:  I Kissin
Journal:  Anesthesiology       Date:  2000-10       Impact factor: 7.892

2.  The incidence of complications associated with retrobulbar injection of anaesthetic for ophthalmic surgery.

Authors:  S Ruben
Journal:  Acta Ophthalmol (Copenh)       Date:  1992-12

3.  Prospective study of the effectiveness of retrobulbar and peribulbar anesthesia for anterior segment surgery.

Authors:  P A Shriver; S Sinha; J H Galusha
Journal:  J Cataract Refract Surg       Date:  1992-03       Impact factor: 3.351

4.  Periocular versus general anesthesia for ocular enucleation.

Authors:  Kimberly G Yen; Victor M Elner; David C Musch; Christine C Nelson
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2008 Jan-Feb       Impact factor: 1.746

5.  A comparison of regional versus general anesthesia for ambulatory anesthesia: a meta-analysis of randomized controlled trials.

Authors:  Spencer S Liu; Wyndam M Strodtbeck; Jeffrey M Richman; Christopher L Wu
Journal:  Anesth Analg       Date:  2005-12       Impact factor: 5.108

6.  Site of service, anesthesia, and postoperative practice patterns for oculoplastic and orbital surgeries.

Authors:  M Bartamian; D R Meyer
Journal:  Ophthalmology       Date:  1996-10       Impact factor: 12.079

7.  Evisceration with equatorial sclerotomy for phthisis bulbi and microphthalmos.

Authors:  Dan Georgescu; M Reza Vagefi; Chun Cheng Lin Yang; John McCann; Richard L Anderson
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2010 May-Jun       Impact factor: 1.746

8.  Patient satisfaction and results after evisceration with a split-sclera technique.

Authors:  S Masdottir; S Sahlin
Journal:  Orbit       Date:  2007-12

9.  Localization of local anesthetic solution by magnetic resonance imaging.

Authors:  Leila Niemi-Murola; Kari Krootila; Riku Kivisaari; Aki Kangasmäki; Leena Kivisaari; Eeva-Liisa Maunuksela
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

10.  Effect of preemptive retrobulbar analgesia on perioperative hemodynamics and postoperative pain after enucleation.

Authors:  R Patrick Yeatts; Wendy Doneyhue; Phillip E Scuderi; Chadwick R Brasington; Robert James
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-05       Impact factor: 1.746

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.